Bone metabolism after total hip revision surgery with impacted grafting: evaluation using H2 15O and [18F]fluoride PET; a pilot study

Mol Imaging Biol. 2008 Sep;10(5):288-93. doi: 10.1007/s11307-008-0153-4. Epub 2008 Jun 10.

Abstract

Purpose: To evaluate bone blood flow and bone formation in patients after total hip revision surgery with impacted bone grafting using H2 15O and [18F]fluoride positron emission tomography (PET).

Procedures: To asses bone blood flow and bone metabolism in bone allograft after impaction grafting, four patients treated with total hip revision surgery were enrolled prospectively in this study. Six patients scheduled for primary hip arthroplasties were included as a control group. The study protocol consisted of three H2 15O and [18F]fluoride PET scans in each patient.

Results: Bone blood flow increased significantly compared to the preoperative state in patients treated for primary hip arthroplasty. In patients undergoing revision surgery, bone blood flow was twofold to threefold higher compared to the preoperative state, but did not reach significance. Bone metabolism in patients undergoing revision was threefold higher 2 weeks postoperatively compared to the primary hip group. We found a significant correlation between Ki and bone blood flow.

Conclusions: Allogeneic bone grafts induce a higher rate of local periprosthetic bone formation compared to periprosthetic bone formation after a primary total hip placement. In vivo coupling between bone blood flow and bone metabolism suggests that bone metabolism in allogeneic bone grafts may partly rely on bone blood flow adaptations.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bone and Bones / metabolism*
  • Deuterium
  • Female
  • Fluorine Radioisotopes
  • Hip Dislocation / diagnostic imaging*
  • Hip Dislocation / metabolism*
  • Hip Dislocation / surgery
  • Hip Prosthesis*
  • Humans
  • Male
  • Oxygen Radioisotopes
  • Pilot Projects
  • Positron-Emission Tomography / methods*
  • Treatment Outcome

Substances

  • Fluorine Radioisotopes
  • Oxygen Radioisotopes
  • Deuterium